Nuvation Bio is a privately-held biopharmaceutical company currently operating in stealth mode that is focused on the development of next generation therapies that will target the foremost unmet needs in oncology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/29/19 | $275,000,000 | Series A |
Aisling Capital Altitude Life Science Ventures Boxer Capital of the Tavistock Group EcoR1 Capital EDBI Fidelity Management & Research Company Omega Funds  Pavilion Capital Perceptive Advisors Redmile Group Surveyor Capital The Baupost Group | undisclosed |
